Source Search Page

favicon geneonline.com

CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth

19+ hour, 39+ min ago — 

...Fostering Collaboration as Regenerative Medicine Industry Matures... ...Forge Strategic Partnership to Advance CGT Industry Growth [Tokyo... ...Cyto-Facto Inc., based in Japan, provides contract manufacturing... ...industry....

favicon geneonline.com

The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive

1+ week ago — 

...The lawsuits against Eli Lilly and Novo Nordisk highlight concerns... ...and Ozempic.... ...Mounjaro (tirzepatide), from Eli Lilly, rivals Novo Nordisk’s Ozempic... ...Whilst Eli Lilly’s lawsuits have been dismissed, Novo Nordisk has...

favicon geneonline.com

Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation...

1+ week ago — 

...Published in the April 12 issue of the journal Science Advances,... ...researchers and engineers from Rice University have achieved a groundbreaking... ...Sunil Sheth (from McGovern Medical School at UTHealth Houston), this... ...Sameer Sheth (from Baylor College of Medicine) and Dr....

favicon geneonline.com

Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!

1+ week ago — 

...Annual Biomedical Forum, a premier event bringing together professionals... ...GeneOnline proudly presents the Southern California Association for... ...  Speaker: Abraham Phillip Lee Dr.... ...The SABPA OC/LA Annual Biomedical Forum is one of our major events...

favicon geneonline.com

Sequencing Revolution Spotlights the Titans of NGS Innovation

1+ week ago — 

...Notable rivals, such as PacBio, Singular Genomics, and Element Biosciences... ..., challenging the established market leader, Illumina.... ...Additionally, workflow solution providers Agilent Technologies, QIAGEN... ...Providers of Sanger Sequencing Instrumentation....

favicon geneonline.com

Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy

2+ week ago — 

...In collaboration with the AACR Chemistry in Cancer Research Working... ...Meeting 2024 in San Diego, showcased twelve innovative oncology... ...breast cancer and metastatic high-grade serous ovarian cancer (NCT06188520... ...prostate tumors to an AR-dependent state....

favicon geneonline.com

Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition...

2+ week ago — 

...On Wednesday, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)... ...announced its acquisition of Alpine Immune Sciences, Inc.... ...Now, with the acquisition of Alpine Immune Sciences, Vertex stands... ...initiatives,” Reshma Kewalramani, CEO of Vertex, emphasized during...

favicon geneonline.com

Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists

2+ week ago — 

...Bayer Signs New Partnership with Google Cloud, Joining Hands for... ...In January 2023, for example, Bayer and Google Cloud signed a collaboration... ...Thomas Kurian, CEO of Google Cloud, underscored the potential of... ...Related article: Bayer Signs Up To Google Cloud To Boost Drug Discovery...

favicon geneonline.com

AACR Showcases Breakthroughs in Novel Breast Cancer Diagnosis and Treatment Strategies

2+ week ago — 

...Recent breakthroughs presented at the American Association for Cancer... ...The landscape of cancer treatment is rapidly evolving with the emergence... ...Yap, from The University of Texas MD Anderson Cancer Center, highlighted... ...In a collaboration with the University of Kansas Medical Center,...

favicon geneonline.com

Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024...

2+ week ago — 

...Exciting advancements in prostate cancer research, shared at the... ...are transforming the outlook for patients grappling with the disease... ...for Prostate Disease Research (CPDR), were analyzed.... ...Charles Link and his team, combines a two-step strategy targeting...

 


**Content is provided on an “as is” basis. 4Internet, LLC makes no commitments regarding the content. What you see here may not be accurate and should not be relied upon. The content does not necessarily represent the views and opinions of 4Internet, LLC. You use this service and everything you see here at your own risk.